Neuramin (Thiamine)

Thiamine serves as a cofactor for key enzymes in carbohydrate metabolism, including pyruvate dehydrogenase, α‑ketoglutarate dehydrogenase, and transketolase. By supporting these enzymatic steps, it enables efficient energy production, nerve function, and synthesis of nucleic acids, thereby correcting metabolic disturbances caused by deficiency.

The appropriate dose of Neuramin is determined by the prescribing healthcare professional based on the patient’s clinical condition, severity of deficiency, route of administration, and individual health factors. Dosage regimens are not standardized and should follow the prescriber’s instructions.

Safety data for thiamine in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Neuramin to pregnant or breastfeeding individuals. Consultation with a medical professional is essential.

To place an order, submit an enquiry on the Neuramin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Neuramin is a sterile injectable form of thiamine, offering rapid systemic availability compared with oral tablets or capsules, which may be limited by gastrointestinal absorption. For acute deficiency or neurological emergencies, injectable thiamine provides faster correction, while oral formulations are suitable for maintenance therapy.

Neuramin should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability and sterility.

Neuramin is administered by a qualified healthcare professional via intramuscular or intravenous injection. The route, injection site, and infusion rate are selected according to the patient’s condition and the prescriber’s orders.

Serious adverse reactions, although rare, include anaphylaxis, severe hypersensitivity (e.g., rash, angioedema), hypotension, cardiac arrhythmias, and neurological events such as seizures. Immediate medical attention is required if any of these symptoms occur after administration.

Neuramin is contraindicated in individuals with a known hypersensitivity to thiamine or any component of the injectable formulation. Patients with uncontrolled severe cardiac disease should use it only under close medical supervision.